GGrantIndex
Sort

23,748 grants matching melanoma

Promoting the generation of long-lived, anti-tumor memory T cells with IFN-alpha

$295,065
Willem W Overwijk · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA

Molecular Design of Filopodia, Cell's Sensory Organelles

$295,035
University Of Pennsylvania · R01 · FY2004 · GM

Cox-2 as a Marker of Neoplasia: Novel Optical Imaging Agents

$295,025
David W. Piston · Stanford University · U54 · FY2008 · CA

Cancer and Leukemia Group B

$295,000
University Of Chicago · U10 · FY2003 · CA

STTR Phase I: Monobenzone (MBEH) Supercarriers: Production and Melanoma Treatment

$295,000
Kettil Cedercreutz · Temprian Oncology, Inc. · · FY2023 · TIP

Mouse Core

$294,997
Shikhar Mehrotra · Loyola University Chicago · P01 · FY2012 · CA

A role for c-Abl/Arg in melanoma progression

$294,962
Rina Plattner · University Of Kentucky · R01 · FY2013 · CA

NO in Tumor Angiogenesis,Microcirculation &Rad.Therapy

$294,946
Massachusetts General Hospital · R01 · FY2003 · CA

NO in Tumor Angiogenesis,Microcirculation &Rad.Therapy

$294,946
Massachusetts General Hospital · R01 · FY2004 · CA

NO in Tumor Angiogenesis,Microcirculation &Rad.Therapy

$294,946
Massachusetts General Hospital · R01 · FY2005 · CA

NO in Tumor Angiogenesis,Microcirculation &Rad.Therapy

$294,946
Massachusetts General Hospital · R01 · FY2002 · CA

Transduction of Hematopoietic Stem Cells for Enhanced Immunotherapy of Melanoma

$294,932
Donald B Kohn · California Institute Of Technology · P01 · FY2010 · CA

ADHESION AND ERK SIGNALING IN MELANOMA

$294,911
Andrew E Aplin · Thomas Jefferson University · R01 · FY2011 · GM

ADHESION AND ERK SIGNALING IN MELANOMA

$294,911
Andrew E Aplin · Thomas Jefferson University · R01 · FY2012 · GM

Mechanism and Inhibition of Collagenolytic Activity

$294,875
Gregg B Fields · Florida Atlantic University · R01 · FY2015 · CA

Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer

$294,868
Mohammad Athar · University Of Alabama At Birmingham · R01 · FY2014 · CA

Myxoma Virus (MV) Oncolysis for treating human cancer

$294,868
Grant McFadden · University Of Florida · R01 · FY2011 · CA

The role of HEF1 protein in division and invasion of metastatic breast cancer

$294,868
Elena Nikolaevna Pugacheva · West Virginia University · R01 · FY2011 · CA

Myxoma Virus (MV) Oncolysis for treating human cancer

$294,868
Grant McFadden · University Of Florida · R01 · FY2012 · CA

The role of HEF1 protein in division and invasion of metastatic breast cancer

$294,868
Elena Nikolaevna Pugacheva · West Virginia University · R01 · FY2012 · CA

Eastern Cooperative Oncology Group

$294,857
Patrick J Loehrer · Indiana University Indianapolis · U10 · FY2010 · CA

KISS1: Defining Mechanisms for Antimetastatic Therapy

$294,765
Danny R Welch · University Of Alabama At Birmingham · R01 · FY2010 · CA

Synergy of the innate and acquired immune responses in tumor immunology

$294,696
Randolph J. Noelle · Dartmouth College · R01 · FY2011 · CA

Anti-CD20 CTL for Therapy of Mantle Cell Lymphoma

$294,687
Oliver W. Press · Fred Hutchinson Cancer Research Center · R21 · FY2006 · CA

Chemically Programmed Antibodies for Cancer Therapy

$294,676
Carlos F Barbas · Scripps Research Institute, The · R01 · FY2008 · CA